Background Hemodialysis patients experience poor outcomes associated with the presence of atherosclerosis, particularly lower-extremity peripheral artery disease (PAD). Prevalence of PAD is known to vary between ethnic groups; however, no information on ethnic-specific PAD prevalence in a hemodialysis cohort is available.
Introduction
Patients with chronic kidney disease (CKD) requiring hemodialysis have high rates of lower-extremity atherosclerosis, where prevalence of peripheral artery disease (PAD) ranges from 16.6 to 38.5 %, compared to 4.4 to 29 % in the general population [1] [2] [3] [4] . In patients receiving hemodialysis, PAD is associated with increased hospitalization (hazard ratio (HR) 1.19, p<0.0001) and increased rates of myocardial infarction (MI) and stroke [5, 6] . Concomitant PAD is also an independent predictor of mortality in hemodialysis patients (HR 1.67, p=0.004) [7] .
Similarly, PAD is also an independent predictor of these poor outcomes in patients with coronary artery disease (CAD), and within this population, there is a significant ethnic variation in PAD prevalence [8] [9] [10] . Black populations have high rates of diabetes and CAD and a high prevalence of PAD compared to all other ethnic groups [11] [12] [13] . While South Asians also have a high prevalence of PAD risk factors including diabetes and CAD, they appear to have a paradoxically lower prevalence of PAD compared to White Europeans [14] .
Prognosis of CKD also varies among ethnic groups [15] . Chinese and South Asians at equal glomerular filtration rates (GFR) and proteinuria levels have a lower risk of mortality than Whites [15] . When comparing Black and White ethnic groups, although the Black population develops end stage renal disease (ESRD) much earlier, once the disease progresses to where the patient requires dialysis, mortality in the White population becomes significantly higher [10] .
While ethnic differences have been observed in both CKD and PAD prevalence, few studies have focused on the ethnic PAD prevalence within a hemodialysis cohort [10] . Our study examines the differences in PAD prevalence in patients undergoing hemodialysis.
Methods

Study Design
We conducted a secondary analysis of data from the Canadian Kidney Dialysis Cohort Study (CKDCS) [16] . The CKDCS is a large, prospective observational study of all consenting adults commencing hemodialysis treatment in multiple ethnically diverse major centres across Canada [16] . CKDCS was conducted according to the principles of the Declaration of Helsinki and approved by the ethics boards of each participating centre [16] .
Study Participants
Our study sample included 1293 adult (≥18 years of age) hemodialysis patients from Edmonton, Calgary and Vancouver. All available patients from the database were included provided they had completed the baseline cohort study questionnaire between March 23, 2005, and December 20, 2011.
Data Collection
Baseline demographic data and clinical history from CKDCS were collected by structured interview and supplemented by clinical record. Ethnicity was self-identified. The baseline data collection was conducted within 8 weeks of the patient starting hemodialysis.
Data Analysis
Ethnicities were separated into groups based on the following classifications used by the CKDCS: Aboriginal (North American Indian, Métis, Inuit); Asian (Chinese, Japanese, Vietnamese, Korean, Taiwanese); Black (African, Caribbean, South American, Cuban); Middle Eastern (Saudi Arabian, Iranian, Iraqi, Algerian, Jordanian, Syrian, Armenian); Pacific Islander (Filipino, Fijian, Hawaiian, Samoan); South Asian (Indian, Pakistani, Bangladeshi) and White/Caucasian (French Canadian, European, Australian, Russian ancestry or non-black Hispanic). For this secondary analysis, the patient was considered to have PAD if they answered yes to having any one of the following: previous claudication symptoms, current claudication symptoms, gangrene, previous vascular intervention or previous amputation due to vascular disease. Data are presented as number of cases with characteristic of interest and as a percent of the total available responses for that ethnic group. Prevalence differences were compared using Chi-squared tests and oneway ANOVA with Tukey's HSD (SPSS Inc., Version 17: Chicago, IL, USA).
Results
Characteristics of the patients included in the study, stratified by ethnic group, are shown in Table 1 . The mean age of the population sample was 60.3 years (standard deviation (SD) 15.6). Aboriginals were significantly younger compared to Whites (p<0.001). Prevalence of hypertension ranged from 84.6 % in Middle Eastern patients to 94.8 % in South Asians. Documented CAD was less common, with an average prevalence of 24.7 % ranging from 7.7 % in Middle Easterners to 25.8 % in Aboriginals. Diabetes was present in 51.4 % of the cohort, with Aboriginals having a significantly higher prevalence compared to Whites (68.8 vs. 48.3 %, p<0.001). Compared to Aboriginals, Blacks and Whites, South Asians had borderline significantly fewer cases of long-duration diabetes (>10 years, p=0.046). Large diversity in smoking habits were found across the ethnic groups with Whites and Aboriginals having significantly lower rates of non-smokers compared to the other ethnic groups.
In the 247 patients identified with symptomatic PAD, there were no significant ethnic differences in the comorbidities between ethnic groups with the exception of patients who had never smoked, warfarin use, and patients diagnosed with diabetes within the last year (Table 2 ). Asians and South Asians had significantly less smokers compared to Whites, while Whites had significantly less warfarin use compared to Blacks and South Asians, albeit with very few cases. The mean age was 60.8 years (SD 13.7) and the majority of patients were male (59.5 %). Hypertension was highly prevalent with an average of 90.7 %, ranging from 89.2 % in Whites to 100 % in five of the seven ethnic groups. The overall prevalence of diabetes was also high at 66.8 %, ranging from 65.5 % in Whites to 100 % in Pacific Islanders.
Overall PAD prevalence was 19.1 % (n=247), ranging from 7.7 to 20.3 % across the various ethnic groups. PAD prevalence was highest in Whites (20.3 %) followed by Aboriginals (19.4 %). The lowest prevalence was in persons from the Middle East (7.7 %) followed by Pacific Islanders (9.8 %). We found no statistically significant differences in PAD prevalence between ethnic groups.
Discussion
PAD has been associated with higher morbidity and mortality in both CKD and CAD patients [5, 10] . Ethnic variations in prevalence of PAD have been found in the CAD population, yet little data is available to examine these patterns in patients with CKD receiving hemodialysis [10] . In our study, we found a high prevalence of symptomatic PAD, but did not find any statistically significant differences in PAD prevalence by ethnicity, suggesting ethnicity may not play a major role in PAD prevalence in this population. Overall, we found a PAD prevalence of 19.1 % in the hemodialysis cohort. These results agree with previous studies which found a 19 % prevalence in European patients with chronic renal failure stages IV/V [17] (no dialysis) and a study of ESRD hemodialysis patients across ten European countries where the PAD prevalence ranged from 17.5 to 37.8 % [5] . These rates are slightly higher than the 15 % reported by the United States Renal Data System (USRDS) of patients undergoing incident dialysis where PAD was defined using only clinical symptoms [2] . Although we found the prevalence among Asians was numerically lower than in people of other ethnicities at 10.9 %, the difference was not statistically significant. However, studies done in Japan have reported a PAD prevalence of 22.1 % in hemodialysis patients using the gold standard ankle-brachial index (ABI) diagnosis [7] , which reflects a limitation in our case definition (as up to 50 % of patients with PAD are asymptomatic) [4] .
One unexpected finding was a similar PAD prevalence between Whites and South Asians. Previous research has indicated that South Asians have significantly less PAD compared to White Europeans [14] . We hypothesized this ethnic disparity would be similar in hemodialysis patients. One possible explanation for the similar rates is the select nature of hemodialysis populations. Specifically, since vascular disease may contribute to both CKD and PAD, it is possible that the presence of CKD selects for people who are at excess risk of PAD-regardless of ethnicity. Similar considerations might apply to other factors (such as vasculitis) which could contribute to the risk of both CKD and PAD. Further research into changes of PAD prevalence through different stages of CKD for the different ethnic groups may shed some light on this finding.
This study was limited in that the gold standard for diagnosis of PAD (ABI) was not available. Sole reliance on clinical symptoms likely results in an up to 85 % underestimation of PAD prevalence [4] . There may also be differences in symptom reporting between ethnic groups. In addition, the number of cases in each ethnic group with PAD was relatively small; therefore, we may have been statistically underpowered to detect a difference.
Conclusion
We did not observe ethnic differences in PAD prevalence in this hemodialysis cohort. Ethnicity is not likely a key factor in the prevalence of PAD in hemodialysis patients. The high prevalence of PAD supports further research in the utility of PAD screening in early stages of CKD to implement treatments for PAD earlier. Values are n (%) or mean (SD) CAD coronary artery disease, PV peripheral vascular, PAD peripheral artery disease
